Topic: Flibanserin

The FDA approved Addyi, a drug marketed as "female Viagra" to treat hypoactive sexual desire disorder (HSDD). The hosts criticize the approval, characterizing it as the result of a sophisticated public relations campaign called "Even the Score" rather than sound science. They highlight significant side effects including nausea, sleepiness, and fainting when combined with alcohol.

A media analysis reveals that clinical trial participant Amanda Parrish appeared on multiple networks including ABC, CBS, and local stations using a scripted "light switch" metaphor to describe the drug's effects. Despite 11,000 participants in the trials, Parrish is identified as the primary anecdotal source used by the media. The hosts argue the drug's efficacy is marginal, reportedly resulting in only one additional "satisfying sexual event" per month.